| RS1563946658 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS1563948056 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS1563948951 |
TJP2
|
Health Risk |
Pathogenic |
— |
| RS1563950539 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestasis, progressive familial intrahepatic |
| RS1563959514 |
RORB
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, idiopathic generalized |
| RS1563960433 |
CREB3;GBA2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 46 |
| RS1563961179 |
APTX
|
Health Risk |
Pathogenic |
— |
| RS1563963464 |
APTX
|
Health Risk |
Likely pathogenic |
Ataxia, early-onset |
| RS1563966097 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Sialuria, GNE myopathy |
| RS1563967576 |
APTX
|
Health Risk |
Likely pathogenic |
— |
| RS1563974797 |
VPS13A
|
Health Risk |
Pathogenic |
primray hypomagnesemia with secondary hypocalcemia, primray hypomagnesemia with secondary hypocalcemia |
| RS1563976866 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS1563978827 |
EEF1D
|
Health Risk |
Pathogenic |
Autosomal recessive non-syndromic intellectual disability, Neurodevelopmental disorder with thin corpus callosum |
| RS1563979243 |
FBP1
|
Health Risk |
Pathogenic |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS1563980403 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1, Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 |
| RS1563980966 |
VCP
|
Health Risk |
Likely pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS1563980979 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS1563981227 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS1563981743 |
MYORG
|
Health Risk |
Likely pathogenic |
Basal ganglia calcification, idiopathic |
| RS1563981857 |
MYORG
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS1563982489 |
MYORG
|
Health Risk |
Likely pathogenic |
Basal ganglia calcification, idiopathic |
| RS1563983151 |
TOPORS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 31, Retinal dystrophy |
| RS1563983184 |
FBP1
|
Health Risk |
Pathogenic |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS1563983269 |
FBP1
|
Health Risk |
Likely pathogenic |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS1563984164 |
FBP1
|
Health Risk |
Likely pathogenic |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS1563984976 |
FANCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group G |
| RS1563986439 |
FANCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS1563986833 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1563988849 |
NPR2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS1563989427 |
TPK1
|
Health Risk |
Likely pathogenic |
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency, Childhood encephalopathy due to thiamine pyrophosphokinase deficiency |
| RS1563991556 |
FBP1
|
Health Risk |
Pathogenic |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS1563993649 |
NPR2
|
Health Risk |
Likely pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS1563996824 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1563998317 |
PIGO
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1564004796 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1564005155 |
KAT6A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1564005341 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1564008885 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1564009755 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564010191 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1564012541 |
PSAT1
|
Health Risk |
Pathogenic |
Neu-Laxova syndrome 2, Neu-Laxova syndrome 2 |
| RS1564013046 |
KAT6A
|
Health Risk |
Likely pathogenic |
— |
| RS1564016699 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1564019780 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1564025732 |
DOCK8
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS1564026963 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS1564029811 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, ankyrin-B-related |
| RS1564030530 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564030723 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1564030910 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Basal cell carcinoma |
| RS1564031259 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564032829 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Medulloblastoma |
| RS1564034077 |
AGTPBP1
|
Health Risk |
Pathogenic |
Neurodegeneration, childhood-onset |
| RS1564034820 |
KAT6A
|
Health Risk |
Pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1564035076 |
B4GALT1
|
Health Risk |
Pathogenic |
B4GALT1-congenital disorder of glycosylation, B4GALT1-congenital disorder of glycosylation |
| RS1564035949 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564035967 |
AGTPBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration, childhood-onset |
| RS1564038389 |
KAT6A
|
Health Risk |
Pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1564038539 |
KAT6A
|
Health Risk |
Pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Inborn genetic diseases |
| RS1564039543 |
KAT6A
|
Health Risk |
Pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1564041582 |
AGTPBP1
|
Health Risk |
Pathogenic |
Neurodegeneration, childhood-onset |
| RS1564045331 |
XPA
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum group A |
| RS1564046794 |
AGTPBP1
|
Health Risk |
Likely pathogenic |
Neurodegeneration, childhood-onset |
| RS1564050178 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564050405 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564051237 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564051834 |
PTCH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1564053040 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564054554 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1564055259 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Basal cell carcinoma |
| RS1564055606 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564055612 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1564055868 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564058147 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564058222 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564061618 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1564061982 |
BICD2
|
Health Risk |
Pathogenic |
Spinal muscular atrophy, lower extremity-predominant |
| RS1564062144 |
HNRNPK
|
Health Risk |
Likely pathogenic |
Au-Kline syndrome, Au-Kline syndrome |
| RS1564063386 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564063967 |
HNRNPK
|
Health Risk |
Pathogenic |
Au-Kline syndrome, Au-Kline syndrome |
| RS1564065545 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS1564067737 |
ANK2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1564069651 |
AGTPBP1
|
Health Risk |
Likely pathogenic |
Global developmental delay, Aplasia/Hypoplasia of the cerebellum |
| RS1564069807 |
AGTPBP1
|
Health Risk |
Likely pathogenic |
Global developmental delay, Motor polyneuropathy |
| RS1564071824 |
AGTPBP1
|
Health Risk |
Pathogenic |
Neurodegeneration, childhood-onset |
| RS1564072453 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1564072540 |
ELP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Medulloblastoma, Familial dysautonomia |
| RS1564072946 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS1564077060 |
CA2
|
Health Risk |
Pathogenic |
— |
| RS1564077207 |
AGO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Lessel-Kreienkamp syndrome, Lessel-Kreienkamp syndrome |
| RS1564077542 |
ALDOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS1564084140 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS1564088181 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1564093439 |
ELP1
|
Health Risk |
Likely pathogenic |
— |
| RS1564096221 |
SIGMAR1
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 2, Autosomal recessive distal spinal muscular atrophy 2 |
| RS1564096502 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS1564096761 |
SIGMAR1
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 2, Amyotrophic lateral sclerosis type 16 |
| RS1564100957 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1564101619 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1564102412 |
ELP1
|
Health Risk |
Likely pathogenic |
— |